RU2015147321A - Method for endoscopic treatment of gastroduodenal ulcer bleeding - Google Patents

Method for endoscopic treatment of gastroduodenal ulcer bleeding Download PDF

Info

Publication number
RU2015147321A
RU2015147321A RU2015147321A RU2015147321A RU2015147321A RU 2015147321 A RU2015147321 A RU 2015147321A RU 2015147321 A RU2015147321 A RU 2015147321A RU 2015147321 A RU2015147321 A RU 2015147321A RU 2015147321 A RU2015147321 A RU 2015147321A
Authority
RU
Russia
Prior art keywords
bleeding
endoscopic treatment
gastroduodenal ulcer
ulcer bleeding
ulcer
Prior art date
Application number
RU2015147321A
Other languages
Russian (ru)
Other versions
RU2633588C2 (en
Inventor
Евгений Федорович Чередников
Михаил Николаевич Романцов
Игорь Федорович Овчинников
Александр Анатольевич Глухов
Вадим Владимирович Адианов
Анастасия Тихоновна Высоцкая
Original Assignee
Евгений Федорович Чередников
Михаил Николаевич Романцов
Игорь Федорович Овчинников
Александр Анатольевич Глухов
Вадим Владимирович Адианов
Анастасия Тихоновна Высоцкая
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Евгений Федорович Чередников, Михаил Николаевич Романцов, Игорь Федорович Овчинников, Александр Анатольевич Глухов, Вадим Владимирович Адианов, Анастасия Тихоновна Высоцкая filed Critical Евгений Федорович Чередников
Priority to RU2015147321A priority Critical patent/RU2633588C2/en
Publication of RU2015147321A publication Critical patent/RU2015147321A/en
Application granted granted Critical
Publication of RU2633588C2 publication Critical patent/RU2633588C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (1)

Способ эндоскопического лечения язвенного гастродуоденального кровотечения, включающий комбинированное применение гемостатических средств и гранулированного сорбента при проведении лечебной эндоскопии, отличающийся тем, что на кровоточащий язвенный дефект с помощью инсуффлятора вначале наносят порошкообразные лиофилизат (НовоСэвен) и желпластан в равных количествах по 0,1 г каждый с расстояния 1,0 см от кровоточащего дефекта, а затем инсуффлируют диовин в количестве 0,3 г с расстояния 1,5 см от язвенной поверхности.A method of endoscopic treatment of gastroduodenal ulcer bleeding, including the combined use of hemostatic agents and a granular sorbent during therapeutic endoscopy, characterized in that the powdered lyophilisate (NovoSeven) and gelplastan in equal amounts of 0.1 g each are applied first to an bleeding ulcer defect a distance of 1.0 cm from the bleeding defect, and then diovin is insufflated in an amount of 0.3 g from a distance of 1.5 cm from the ulcer surface.
RU2015147321A 2015-11-03 2015-11-03 Method for endoscopic treatment of ulcerous gastroduodenal bleeding RU2633588C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015147321A RU2633588C2 (en) 2015-11-03 2015-11-03 Method for endoscopic treatment of ulcerous gastroduodenal bleeding

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015147321A RU2633588C2 (en) 2015-11-03 2015-11-03 Method for endoscopic treatment of ulcerous gastroduodenal bleeding

Publications (2)

Publication Number Publication Date
RU2015147321A true RU2015147321A (en) 2017-05-10
RU2633588C2 RU2633588C2 (en) 2017-10-13

Family

ID=58698333

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015147321A RU2633588C2 (en) 2015-11-03 2015-11-03 Method for endoscopic treatment of ulcerous gastroduodenal bleeding

Country Status (1)

Country Link
RU (1) RU2633588C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2763754C1 (en) * 2021-05-05 2022-01-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Method for endoscopic treatment of erosive and ulcerative lesions of the stomach and duodenum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE428445T1 (en) * 2000-02-11 2009-05-15 Bayer Healthcare Llc CLOTTING FACTOR VII OR VIIA CONJUGATES
RU2357685C1 (en) * 2008-01-09 2009-06-10 Георгий Кириллович Жерлов Method of endoscopic hemostasis of bleeding from pyloroduodenal ulcers

Also Published As

Publication number Publication date
RU2633588C2 (en) 2017-10-13

Similar Documents

Publication Publication Date Title
WO2017163132A3 (en) Use of umbilical cord blood derived exosomes for tissue repair
WO2020106642A8 (en) 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin
RU2016141570A (en) FGFR INHIBITOR AND IGF1R INHIBITOR COMBINATIONS
WO2015179559A3 (en) Pyrazole compounds and methods of making and using same
WO2015021358A3 (en) Compounds and methods for inhibiting phosphate transport
RU2018145985A (en) ACTIVIN-ACTRII ANTAGONISTS AND THEIR APPLICATION FOR TREATMENT OF BONE TISSUE DISORDERS AND OTHER DISORDERS
WO2015010078A3 (en) Substituted 6,5-fused bicyclic heteroaryl compounds
EA201790142A1 (en) TREATMENT OF LEUKEMIA INHIBITORS HISTONDEACETYLASE
EA201890771A1 (en) SALT AND SOLID FORMS OF MONOBACTAN ANTIBIOTICS
EA201791898A1 (en) NEW ANTIBODIES CONNECTING WITH TFPI AND CONTAINING THEIR COMPOSITION
EA201790950A1 (en) METHODS AND COMPOSITIONS, IN PARTICULAR, FOR TREATING THE SYNDROME OF DEFICIENCY ATTENTION
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
WO2016094899A3 (en) Treatment of hmgb1-mediated inflammation
WO2016020880A3 (en) Angiopoietin-like 4 antibodies and methods of use
JP2014139182A5 (en)
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
WO2016020882A3 (en) Angiopoetin-like 4 (angptl4) antibodies and methods of use
EA201692518A2 (en) METHODS TO IMPROVE MYOCARDIAL PERFORMANCE IN PATIENTS AFTER FONTENE OPERATION USING UDENAFIL COMPOSITIONS
NZ757595A (en) Method of treatment of hypoxia inducible factor (hif)-related conditions
WO2015074010A3 (en) Compositions and methods for cardiac regeneration
RU2015147321A (en) Method for endoscopic treatment of gastroduodenal ulcer bleeding
WO2017087754A3 (en) Compositions and methods of mechanically inducing tissue regeneration
EA201792401A1 (en) COMPOSITIONS FOR PURIFICATION OF THICK INTESTINES AND TREATMENT OF GASTROINTESTINAL DISORDERS
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
RU2016110561A (en) METHOD FOR TREATMENT OF EXPLOSIVE HEMORRHAGIC SYNDROME (MELLORI-WEISS SYNDROME)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20181104